| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2018 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LIBERTY MEDIA CORP DEL | 16 | Q3 2023 | 10.0% |
| AMBAC FINL GROUP INC | 16 | Q3 2023 | 6.2% |
| AQUESTIVE THERAPEUTICS INC | 16 | Q3 2023 | 0.6% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 0.6% |
| DISH NETWORK CORPORATION | 11 | Q2 2022 | 5.5% |
| ISHARES TR | 10 | Q3 2023 | 65.7% |
| ISHARES TR | 10 | Q3 2023 | 72.3% |
| COMPUTE HEALTH ACQUISITIN CO | 10 | Q2 2023 | 0.6% |
| CHURCHILL CAPITAL CORP VII | 9 | Q1 2023 | 0.3% |
| CHURCHILL CAPITAL CORP VI | 9 | Q1 2023 | 0.1% |
View Bracebridge Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Quotient Ltd | February 22, 2023 | 62,030 | 0.3% |
| Clarus Therapeutics Holdings, Inc. | July 06, 2022 | 1,461,822 | 2.8% |
| PERNIX THERAPEUTICS HOLDINGS, INC.Sold out | May 26, 2016 | 0 | 0.0% |
View Bracebridge Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| SC 13G/A | 2024-02-08 |
| SC 13D/A | 2023-11-17 |
| 4 | 2023-11-16 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-08-25 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-08-04 |
| SC 13D | 2023-06-16 |
| SC 13G | 2023-06-15 |
View Bracebridge Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.